Avalon GloboCare Change in Accounts Receivable 2015-2025 | ALBT

Avalon GloboCare change in accounts receivable from 2015 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.

Avalon GloboCare Change in Accounts Receivable 2015-2025 | ALBT

Avalon GloboCare change in accounts receivable from 2015 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$233.7B
Amgen (AMGN)$153.4B
Gilead Sciences (GILD)$148.9B
Vertex Pharmaceuticals (VRTX)$99.4B
Bristol Myers Squibb (BMY)$94.7B
CSL (CSLLY)$83.8B
GSK (GSK)$77.9B
Regeneron Pharmaceuticals (REGN)$59B
Alnylam Pharmaceuticals (ALNY)$56.4B
Argenex SE (ARGX)$39B
BioNTech SE (BNTX)$26.7B
Insmed (INSM)$25.8B
Royalty Pharma (RPRX)$20.2B
Biogen (BIIB)$18.9B
Incyte (INCY)$15.9B
Illumina (ILMN)$15B
Genmab (GNMSF)$14.3B
Genmab (GMAB)$14B
Ascendis Pharma (ASND)$12B
BioMarin Pharmaceutical (BMRN)$10.9B
QIAGEN (QGEN)$10.9B
Swedish Orphan Biovitrum (BIOVF)$10.3B
Exelixis (EXEL)$10.2B
Moderna (MRNA)$10B
Verona Pharma American Depositary Share (VRNA)$9B
Blueprint Medicines (BPMC)$8.3B
Bio-Techne Corp (TECH)$8.3B
Exact Sciences (EXAS)$7.9B
Halozyme Therapeutics (HALO)$7.9B
Roivant Sciences (ROIV)$7.9B